Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05244096 · ClinicalTrials.gov registry record
COVID-19 & Psychiatry: A Retrospective Chart Review
A clinical trial of COVID-19, sponsored by Northwestern University.
- Active
- Registry status
- 65,000
- Enrollment target
- 1
- Study location
NCT05244096: Active study of COVID-19, sponsored by Northwestern University.
NCT05244096 is a study of COVID-19 that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 65,000 participants, above the 38,247-participant average among 298 other COVID-19 trials with a reported enrollment target (70% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05244096, a study of COVID-19, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- 65,000 participants
- Enrollment target
- 1
- Study location
Study Summary
A retrospective chart review study to determine the effects of psychotropic medications and prior psychiatric diagnoses on COVID-19 patients' disease progression, and severity.
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (1)
Illinois
- Northwester Clinical Research Program - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65,000 participants |
| Start Date | 2022-01-12 |
| Est. Completion | 2025-03-30 |
What the registry record for NCT05244096 still lists
NCT05244096 is an observational study that tracks outcomes without assigning an intervention. Its 65,000 participants enrollment target places it among the larger protocols in the corpus, above the 38,247-participant average among 298 other COVID-19 trials with a reported enrollment target (70% higher).
The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT05244096 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05244096 about?
NCT05244096 is a clinical study titled "COVID-19 & Psychiatry: A Retrospective Chart Review". A retrospective chart review study to determine the effects of psychotropic medications and prior psychiatric diagnoses on COVID-19 patients' disease progression, and severity.
What is the current status of trial NCT05244096?
This trial is currently active not recruiting. The enrollment target is 65,000 participants. The study started on 2022-01-12. Estimated completion is 2025-03-30.
What conditions does trial NCT05244096 study?
This clinical trial studies the following conditions: COVID-19.
What interventions are being tested in trial NCT05244096?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT05244096?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05244096 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05244096's enrollment target sits among peer trials
65,000 5th of 298 higher than 294 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04473833 · 65,000 participants · NA
Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer
- NCT05128006 · 63,200 participants
Direct-to-patient Teledermatology and Computer-assisted Diagnosis
- NCT06003192 · 63,000 participants · NA
Screen Smart: Using Digital Health to Improve HIV Screening and Prevention
- NCT00009633 · 68,000 participants
Follow-up Visit of High Risk Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI